Patent Assignment
Reel/Frame 052954/0490
Assignment of Assignor's Interest
Recorded: 2020-06-16
Pages: 9
Assignors
BEARSS, DAVID J.
Executed: 2020-06-03
SIDDIQUI-JAIN, ADAM
Executed: 2020-06-08
WHATCOTT, CLIFFORD J.
Executed: 2020-06-01
WARNER, STEVEN L.
Executed: 2020-05-06
Assignee
TOLERO PHARMACEUTICALS, INC.
3900 N. TRAVERSE MOUNTAIN BLVD., LEHI, UTAH, 84043
Covered Property
(1)
Treatment Regimen for Cancers That Are Insensitive to Bcl-2 Inhibitors Using the Mcl-1 Inhibitor Alvocidib
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger
Jul 10, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 053181/0114 →
Change of Name
Jul 10, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053181/0133 →
Change of Name
Apr 27, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059809/0557 →